FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileIngevity Corporation
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
NGVT
Ingevity Corporation Stock AnalysisComprehensive stock analysis for Ingevity Corporation (NGVT) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisNGVT
NGVT
Ingevity Corporation
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
NGVT
  1. Home
  2. Stocks
  3. Ingevity Corporation

Ingevity Corporation

🇺🇸NGVT•NYSE

Ingevity Corporation

🇺🇸NGVT•NYSE
Market cap
$2.03B
Sentiment

Your view on NGVT

Mkt Cap
$2.03B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Ingevity Corporation

Industry
Chemicals - Specialty
Sector
Basic Materials
CEO
David H. Li
Headquarters
4920 O'Hear Avenue, North Charleston, SC, US
Industry
Chemicals - Specialty
Sector
Basic Materials
CEO
David H. Li
Headquarters
4920 O'Hear Avenue, North Charleston, SC, US
Description

Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals.

The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats.

This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment comprises of pavement technologies, industrial specialties, and engineered polymers.

It manufactures products derived from crude tall oil and lignin extracted from the kraft pulping process, as well as caprolactone monomers and derivatives derived from cyclohexanone and hydrogen peroxide.

This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, industrial intermediates and oilfield, coatings, resins, elastomers, bioplastics, and medical devices.

Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Ingevity Corporation from FRC's valuation model, read against the market price. NGVT last traded at $60.02, 33.8× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Ingevity Corporation. Starting points for Ingevity Corporation: P/E 33.8, EPS $1.74, beta 1.11 — an Chemicals - Specialty name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Ingevity Corporation. Ingevity Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Ingevity Corporation. Trailing twelve-month EPS for Ingevity Corporation stands at $1.74. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$76.67

average of 3 firms, last 12 months

 

$76.67

Low $65.00

Median $82.00

High $83.00

 

Analyst Ratings

Buy13 ratings
  • Strong Buy0
  • Buy10
  • Hold3
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$0.87$1.21$5.39$5.96
Low estimate$0.86$1.19$5.34$5.90
High estimate$0.88$1.22$5.45$6.03
No. of analysts2122
Year-ago EPS$0.58$1.15-$4.611—
Growth+50.6%+4.8%——

1Year-ago EPS includes one-time items; growth not shown.

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$231.90M$252.35M$1.11B$1.12B
Low estimate$229.94M$250.22M$1.10B$1.11B
High estimate$233.86M$254.48M$1.12B$1.13B
No. of analysts1122
Year-ago revenue$255.10M$258.00M$1.17B—
Growth-9.1%-2.2%-5.2%—
Recent analyst actions15 rating and price-target changes, latest Mar 2, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Ingevity Corporation. Ingevity Corporation has reported as a listed company since 2016. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold NGVT20 companies · 8 funds
Compare NGVT with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • AAUCAllied Gold CorporationGold$2.8B
  • ASHAshland Inc.Chemicals - Specialty$3.5B
  • CCThe Chemours CompanyChemicals - Specialty$1.9B
  • ELVRElevra Lithium LimitedOther Precious Metals$454M
  • FMCFMC CorporationAgricultural Inputs$655M
  • IOSPInnospec Inc.Chemicals - Specialty$2.0B
  • KWRQuaker Chemical CorporationChemicals - Specialty$2.6B
  • MTXMinerals Technologies Inc.Chemicals - Specialty$1.9B

More Chemicals - Specialty companies

  • VTXPFVictrex plcOTC$740M
  • VYSTVystar CorporationOTC$985,264
  • WDFCWD-40 CompanyNASDAQ$3.0B
  • WKCMFWacker Chemie AGOTC$4.8B
  • WLABWhite Label Liquid, Inc.OTC$6,378
  • WLKWestlake CorporationNYSE$7.9B
  • YIPCFYip's Chemical Holdings LimitedOTC$140M
  • YMATJ-Star Holding Co., Ltd. Ordinary SharesNASDAQ$3M
  • ZENGZenergy International, Inc.OTC$53,223
  • ZEOOFZeon CorporationOTC$1.8B
  • ZEOOYZeon CorporationOTC$1.9B
  • SEVTSummit Environmental Corporation, Inc.OTC$3,054

ETFs holding Ingevity Corporation

% of the fund

  • IJRiShares Core SP Small-Cap ETF$103.8B in assets0.12%
  • IWMiShares Russell 2000 ETF$76.6B in assets0.07%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.00%
  • VBVanguard Small-Cap ETF$76.9B in assets0.03%
  • GSCGoldman Sachs Small Cap Equity ETF$320M in assets1.04%
  • XSMOInvesco S&P SmallCap Momentum ETF$2.7B in assets0.44%
  • JPSEJPMorgan Diversified Return U.S. Small Cap Equity ETF$575M in assets0.27%
  • EESWisdomTree U.S. SmallCap Earnings Fund$688M in assets0.22%

Largest holders first, then the funds most concentrated in NGVT.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Ingevity Corporation, and how their positions are changing. At a $2.03B market value, institutional positions materially move Ingevity Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Ingevity Corporation executives and directors. Shares of Ingevity Corporation have traded between $28.49 and $60.77 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Ingevity Corporation. Coverage tracks Ingevity Corporation within Chemicals - Specialty (Basic Materials). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Ingevity Corporation.

NGVT Analysis
Fair
Past5
Growth1
Health2
Profit5
Value1

News

Latest Market News